Jabra Enhance Select 50R vs Signia Pure C&G IX

The Jabra Enhance Select 50R is a premium-priced OTC hearing aid at $1,195, earning a B grade with a SoundScore of 3.8/5 in our lab testing. This behind-the-ear device ranks #29 of 65 OTC hearing aids tested, placing it in the top 43% of its category. In our testing, the Enhance Select 50R shows clear strengths in speech clarity for quieter environments, scoring 3.5/5—a solid result that's 0.75 points above the OTC category average. Music streaming is another highlight at 2.8/5, which is 0.88 points above average for the category, though still only mixed in absolute terms. Feedback handling is excellent at 5.0/5, meaning users shouldn't experience whistling issues during normal use. The device's main limitation is speech understanding in noisy environments, where it scores 1.0/5—a low result that falls 0.48 points below the category average. Own-voice comfort lands at a mixed 2.5/5, essentially matching the category average. These results suggest the Enhance Select 50R performs best in quieter listening situations rather than challenging acoustic environments. At this price point, buyers should note that several competitors offer stronger overall performance. The Lucid Tala and Audicus Omni 2 both score above 4.5/5 in the same price range, while Jabra's own Enhance Select 500 scores 4.18/5. Budget-conscious shoppers seeking similar sound quality might also consider lower-priced alternatives like the Sony CRE-C20. The Enhance Select 50R is best suited for those who prioritize quiet conversation clarity and music streaming over performance in noisy settings.

The Signia Pure C&G IX is a premium prescription behind-the-ear hearing aid released in 2023, currently available at $3,298. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.1/5, ranking #20 among 36 prescription hearing aids tested. This device demonstrates consistent strength across multiple performance areas. Speech in quiet scored a solid 4.0/5, sitting 0.65 points above the category average. Speech in noise performance, while above the category average by 0.25 points, remains mixed in absolute terms at 2.2/5—a common challenge across prescription devices. Feedback handling is a standout feature, achieving a perfect 5.0/5 and exceeding the already-high category average. Own-voice comfort scores a solid 3.2/5, running 0.45 points above the category average, which suggests good occlusion management. Music streaming performs solidly at 3.0/5, also above average for the category by 0.36 points. The device supports both iPhone and Android streaming along with hands-free functionality. Professional tuning yields meaningful improvement, with the normalized score increasing from 4.0/5 to 4.5/5. Buyers seeking top-tier performance in this price range should note that competitors like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5) scored higher in our testing. The Pure C&G IX may suit those who prioritize reliable feedback control and balanced everyday performance over maximum speech-in-noise capability.